“Tesla Killer” locks up BILLIONS in funding
>>This tiny stock could soar past Tesla… and make its early investors VERY RICH. Click to learn more… <<

Alex Reid, Founder and Investment Director, Wealthpin
“Tesla Killer” locks up BILLIONS in funding
>>This tiny stock could soar past Tesla… and make its early investors VERY RICH. Click to learn more… <<

Alex Reid, Founder and Investment Director, Wealthpin
Disclaimer: This report is for informational and educational purposes only and does not constitute professional financial or investment advice. Furthermore, mentions of specific veterinary therapeutics
The synthesis of this valuation gap requires understanding market dynamics. Investors assign premium multiples to companion animal health businesses (like Idexx Laboratories or the companion
Adyen (ADYEN.AS): A dominant European horizontal player trading at significantly higher growth multiples—commanding a ~5.0x EV/Revenue multiple and ~21.6x forward EV/EBITDA [cite: 1, 2]—largely due
